What Is a Non Invasive Prenatal Test?
Learn what a non invasive prenatal test (NIPT) is in 2026, how cell-free DNA screening works, and why US moms-to-be choose it. Order a panel today.
A non invasive prenatal test (NIPT) is a blood-based screening that analyzes cell-free DNA from a pregnancy to assess the risk of certain chromosomal conditions, such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. In 2026, NIPT remains the most accurate first-tier screening option for pregnant individuals in the United States, offering detection rates above 99% for common trisomies with a low false-positive rate. Unlike diagnostic procedures, NIPT poses no risk of miscarriage because it requires only a maternal blood draw, typically after 10 weeks of gestation.
How Non Invasive Prenatal Testing Works
During pregnancy, small fragments of DNA from the placenta—called cell-free DNA—circulate in the mother’s blood. A non invasive prenatal test isolates and sequences this cell-free DNA to measure the relative amount of each chromosome. If more DNA from chromosome 21 is detected than expected, it suggests a higher chance of trisomy 21. The test also reports fetal fraction, the percentage of cell-free DNA coming from the placenta; a minimum fetal fraction (often 4% or higher) is needed for reliable results.
What NIPT Screens For
- Trisomy 21 (Down syndrome) – most common chromosomal condition screened.
- Trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) – less common but more severe.
- Sex chromosome aneuploidies – such as Turner syndrome or Klinefelter syndrome (optional).
- Fetal sex – can be determined from the presence of Y-chromosome DNA.
NIPT vs. Other Prenatal Screenings and Tests
NIPT is one of several options in the US prenatal screening landscape. Understanding the differences helps you make an informed choice.
| Test Type | When Offered | Risk Level | What It Detects |
|---|---|---|---|
| Non invasive prenatal test (NIPT) | From 10 weeks | No risk to pregnancy | Common trisomies, sex chromosomes |
| First-trimester screening (ultrasound + blood) | 11–14 weeks | No risk | Risk of Down syndrome, trisomy 18 |
| Quad screen (second-trimester blood test) | 15–22 weeks | No risk | Risk of Down syndrome, trisomy 18, neural tube defects |
| Integrated screening (first + second trimester) | 11–22 weeks | No risk | Combined risk assessment |
| Chorionic villus sampling (CVS) – diagnostic | 10–13 weeks | Small miscarriage risk (~0.5%) | Chromosomal diagnosis |
| Amniocentesis – diagnostic | 15–20 weeks | Small miscarriage risk (~0.1–0.3%) | Chromosomal diagnosis |
Who Should Consider NIPT?
The American College of Obstetricians and Gynecologists recommends offering NIPT to all pregnant individuals, regardless of age or baseline risk. NIPT is often chosen by those who want high-accuracy screening without the risks of chorionic villus sampling or amniocentesis. It is also used in twin pregnancies and can be performed in pregnancies conceived via egg donation or surrogacy. A genetic counselor can help interpret results and discuss next steps, such as confirmatory diagnostic testing if a high-risk result is returned.
Limitations and Important Facts
NIPT is a screening test, not a diagnostic test. A high-risk result should be confirmed with CVS or amniocentesis. False positives can occur, especially for rare conditions. Additionally, NIPT does not screen for all genetic disorders; it does not detect open neural tube defects or most single-gene conditions. Carrier screening is a separate blood test that checks if a parent carries genes for conditions like cystic fibrosis or spinal muscular atrophy—many US providers offer NIPT alongside carrier screening for a more complete picture.
Steps After Your NIPT Results
If your NIPT result is low-risk, no further testing is typically needed for the screened conditions. If the result is high-risk, your healthcare provider will likely recommend a diagnostic test (CVS or amniocentesis) and a referral to a genetic counselor. Some women also choose a prenatal paternity test, which can be done non invasively using the same type of cell-free DNA analysis, though that is a separate service.
Ordering a Prenatal Screening Panel
Now that you understand what a non invasive prenatal test is and how it fits into your prenatal care, you may be ready to take the next step. You can order a prenatal screening panel online directly from our secure platform, receive your kit at home, and get results in as little as 5–7 business days. This comprehensive panel includes NIPT plus carrier screening for the most common inherited conditions, giving you a complete picture of your pregnancy health.
Ready to get screened? Order a prenatal carrier screening panel online through our partner and visit a local lab near you.
Order Prenatal Carrier ScreeningAbout PrenatalScreenings
PrenatalScreenings.com is a local lab information directory. We do not provide medical advice, diagnose conditions, or interpret test results. Always consult a qualified healthcare provider for personal medical guidance.